...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >A(2B) adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation.
【24h】

A(2B) adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation.

机译:A(2B)腺苷受体通过抑制过度的炎症反应,防止败血症引起的死亡。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Despite intensive research, efforts to reduce the mortality of septic patients have failed. Adenosine is a potent extracellular signaling molecule, and its levels are elevated in sepsis. Adenosine signals through G-protein-coupled receptors and can regulate the host's response to sepsis. In this study, we studied the role of A(2B) adenosine receptors in regulating the mortality and inflammatory response of mice following polymicrobial sepsis. Genetic deficiency of A(2B) receptors increased the mortality of mice suffering from cecal ligation and puncture-induced sepsis. The increased mortality of A(2B) knockout mice was associated with increased levels of inflammatory cytokines and chemokines and augmented NF-kappaB and p38 activation in the spleen, heart, and plasma in comparison with wild-type animals. In addition, A(2B) receptor knockout mice showed increased splenic apoptosis and phosphatase and tensin homolog activation and decreased Akt activation. Experiments using bone-marrow chimeras revealed that it is the lack of A(2B) receptors on nonhematopoietic cells that is primarily responsible for the increased inflammation of septic A(2B) receptor-deficient mice. These results indicate that A(2B) receptor activation may offer a new therapeutic approach for the management of sepsis.
机译:尽管进行了深入的研究,但降低败血病患者死亡率的努力仍然失败。腺苷是一种有效的细胞外信号分子,在脓毒症中其水平升高。腺苷通过G蛋白偶联受体发出信号,并可以调节宿主对败血症的反应。在这项研究中,我们研究了A(2B)腺苷受体在调节小鼠败血症后的死亡率和炎症反应中的作用。遗传缺陷的A(2B)受体增加了盲肠结扎和穿刺诱发败血症的小鼠的死亡率。与野生型动物相比,A(2B)基因敲除小鼠的死亡率增加与炎症细胞因子和趋化因子水平的增加以及脾脏,心脏和血浆中NF-κB和p38激活的增加有关。此外,A(2B)受体敲除小鼠显示出脾脏凋亡增加,磷酸酶和肌腱张力同源激活和减少的Akt激活。使用骨髓嵌合体的实验表明,非造血细胞上缺乏A(2B)受体是造成败血性A(2B)受体缺陷型小鼠炎症增加的主要原因。这些结果表明,A(2B)受体激活可能为脓毒症的治疗提供一种新的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号